In the last 12 months, insiders at PALISADE BIO, INC. ($PALI) filed 184 transactions with the SEC: 10 open-market purchases totaling $72,474 and 3 sales totaling $10,491. Net insider sentiment: net buying.
PALISADE BIO, INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Finley John David (CEO, CFO, Director) — 59 transactions totaling $57,476
- Williams Donald Allen (Director) — 15 transactions totaling $39,469
- Jones Mitchell Lawrence (Chief Medical Officer) — 24 transactions totaling $11,348
- Finley John David (CEO, CFO) — 8 transactions totaling $6,818
- Jones Mitchell Lawrence (CEO, CFO, Director) — 6 transactions totaling $1,159
View all SEC Filings for PALISADE BIO, INC. (PALI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 8000 | $0.00 | 16,000.0000 | 149,003,210 | 33.33% | 0.01% |
| Feb. 12, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | S | Common Stock | 1989 | $1.75 | 13,263.0000 | 149,003,210 | 13.04% | 0.00% |
| Feb. 11, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock | 8000 | $0.00 | 15,252.0000 | 149,003,210 | 110.31% | 0.01% |
| Feb. 11, 2026 | Finley John David | CEO, CFO | M | Restricted Stock Units | 13333 | $0.00 | 26,667.0000 | 149,003,210 | 33.33% | 0.01% |
| Feb. 12, 2026 | Finley John David | CEO, CFO | S | Common Stock | 3896 | $1.75 | 27,404.0000 | 149,003,210 | 12.45% | 0.00% |
| Feb. 11, 2026 | Finley John David | CEO, CFO | M | Common Stock | 13333 | $0.00 | 31,300.0000 | 149,003,210 | 74.21% | 0.01% |
| Feb. 9, 2026 | Finley John David | CEO, CFO | A | Restricted Stock Units | 2011000 | $0.00 | 2,011,000.0000 | 149,003,210 | 9999.99% | 1.35% |
| Feb. 9, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 787000 | $0.00 | 787,000.0000 | 149,003,210 | 9999.99% | 0.53% |
| Jan. 16, 2026 | Williams Donald Allen | Director | P | Common Stock | 5000 | $1.67 | 13,728.0000 | 149,003,210 | 57.29% | 0.00% |
| Jan. 9, 2026 | Williams Donald Allen | Director | P | Common Stock | 5000 | $1.88 | 8,728.0000 | 149,003,210 | 134.12% | 0.00% |
| Oct. 6, 2025 | Chuang Emil | Director | A | Restricted Stock Units | 60600 | $0.00 | 60,600.0000 | 4,396,646 | 9999.99% | 1.38% |
| Oct. 6, 2025 | Wei Binxian | Director | A | Restricted Stock Units | 60600 | $0.00 | 60,600.0000 | 4,396,646 | 9999.99% | 1.38% |
| Oct. 6, 2025 | Williams Donald Allen | Director | A | Restricted Stock Units | 182000 | $0.00 | 182,000.0000 | 4,396,646 | 9999.99% | 4.14% |
| Oct. 6, 2025 | Chuang Emil | Director | A | Restricted Stock Units | 510700 | $0.00 | 510,700.0000 | 4,396,646 | 9999.99% | 11.62% |
| Oct. 6, 2025 | Finley John David | CEO, CFO | A | Restricted Stock Units | 9179400 | $0.00 | 9,179,400.0000 | 4,396,646 | 9999.99% | 100.00% |
| Oct. 6, 2025 | Wei Binxian | Director | A | Restricted Stock Units | 510700 | $0.00 | 510,700.0000 | 4,396,646 | 9999.99% | 11.62% |
| Oct. 6, 2025 | Williams Donald Allen | Director | A | Restricted Stock Units | 1538700 | $0.00 | 1,538,700.0000 | 4,396,646 | 9999.99% | 35.00% |
| Oct. 6, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 7665800 | $0.00 | 7,665,800.0000 | 4,396,646 | 9999.99% | 100.00% |
| Sept. 4, 2025 | Williams Donald Allen | Director | A | Phantom Units | 64400 | $0.00 | 64,400.0000 | 4,396,646 | 9999.99% | 1.46% |
| Sept. 4, 2025 | Wei Binxian | Director | A | Phantom Units | 18800 | $0.00 | 18,800.0000 | 4,396,646 | 9999.99% | 0.43% |
| Sept. 4, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | A | Phantom Units | 289000 | $0.00 | 289,000.0000 | 4,396,646 | 9999.99% | 6.57% |
| Sept. 4, 2025 | Chuang Emil | Director | A | Phantom Units | 18800 | $0.00 | 18,800.0000 | 4,396,646 | 9999.99% | 0.43% |
| Sept. 4, 2025 | Finley John David | CEO, CFO | A | Phantom Units | 323400 | $0.00 | 323,400.0000 | 4,396,646 | 9999.99% | 7.36% |
| July 18, 2025 | Chuang Emil | Director | A | Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 4,396,646 | 9999.99% | 0.18% |
| Feb. 11, 2025 | Finley John David | CEO, CFO | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | A | Stock Option (Right to Buy) | 29000 | $0.00 | 29,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Finley John David | CEO, CFO | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | Wei Binxian | Director | M | Comon Stock, par value $0.01 | 388 | $0.00 | 855.0000 | 0 | 83.08% | 0.00% |
| Nov. 21, 2024 | Williams Donald Allen | Director | M | Comon Stock, par value $0.01 | 388 | $0.00 | 3,728.0000 | 0 | 11.62% | 0.00% |
| July 11, 2024 | Wei Binxian | Director | A | Common Stock Options | 2100 | $0.00 | 2,100.0000 | 0 | 9999.99% | 0.00% |
| July 11, 2024 | Williams Donald Allen | Director | A | Common Stock Options | 2100 | $0.00 | 2,100.0000 | 0 | 9999.99% | 0.00% |
| July 11, 2024 | Fischbein Margery B. | Director | A | Common Stock Options | 2100 | $0.00 | 2,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Williams Donald Allen | Director | M | Comon Stock, par value $0.01 | 340 | $0.00 | 3,340.0000 | 0 | 11.33% | 0.00% |
| June 11, 2024 | Wei Binxian | Director | M | Comon Stock, par value $0.01 | 465 | $0.00 | 467.0000 | 0 | 9999.99% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 1622 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3335 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 2111 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 2735 | $0.00 | 3,568.0000 | 0 | 328.33% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 810 | $4.76 | 2,758.0000 | 0 | 22.70% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 1555 | $0.00 | 4,313.0000 | 0 | 56.38% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 461 | $4.76 | 3,852.0000 | 0 | 10.69% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 2735 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 1555 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 1622 | $0.00 | 10,110.0000 | 0 | 19.11% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 467 | $4.76 | 9,643.0000 | 0 | 4.62% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3335 | $0.00 | 12,978.0000 | 0 | 34.58% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 959 | $4.76 | 12,019.0000 | 0 | 7.39% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 2111 | $0.00 | 14,130.0000 | 0 | 17.56% | 0.00% |
| May 28, 2024 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 607 | $4.76 | 13,523.0000 | 0 | 4.30% | 0.00% |
| May 28, 2024 | Williams Donald Allen | Director | P | Comon Stock, par value $0.01 | 1000 | $4.86 | 3,000.0000 | 0 | 50.00% | 0.00% |
| May 24, 2024 | Finley John David | CEO, CFO, Director | P | Common Stock, par value $0.01 | 1000 | $4.81 | 8,488.0000 | 0 | 13.35% | 0.00% |
| May 20, 2024 | Finley John David | CEO, CFO, Director | A | Common Stock, par value $0.01 | 666 | $4.97 | 7,488.0000 | 0 | 9.76% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 61 | $8.46 | 6,822.0000 | 0 | 0.89% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 232 | $0.00 | 1,622.0000 | 0 | 12.51% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 211 | $0.00 | 2,111.0000 | 0 | 9.09% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | M | Common Stock, par value $0.01 | 156 | $0.00 | 880.0000 | 0 | 21.55% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | M | Common Stock, par value $0.01 | 304 | $0.00 | 814.0000 | 0 | 59.61% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 211 | $0.00 | 6,883.0000 | 0 | 3.16% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | F | Common Stock, par value $0.01 | 47 | $8.46 | 833.0000 | 0 | 5.34% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | F | Common Stock, par value $0.01 | 90 | $8.46 | 724.0000 | 0 | 11.06% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 67 | $8.46 | 6,672.0000 | 0 | 0.99% | 0.00% |
| May 6, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 232 | $0.00 | 6,739.0000 | 0 | 3.57% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | M | Restricted Stock Units | 156 | $0.00 | 1,555.0000 | 0 | 9.12% | 0.00% |
| May 6, 2024 | Jones Mitchell Lawrence | CEO, CFO, Director | M | Restricted Stock Units | 304 | $0.00 | 2,735.0000 | 0 | 10.00% | 0.00% |
| March 11, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 5558 | $0.00 | 97,626.0000 | 0 | 6.04% | 0.00% |
| March 11, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 5558 | $0.00 | 50,025.0000 | 0 | 10.00% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock, par value $0.01 | 5820 | $0.00 | 12,800.0000 | 0 | 83.38% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock, par value $0.01 | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock, par value $0.01 | 5820 | $0.00 | 10,920.0000 | 0 | 114.12% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Restricted Stock Units | 5100 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Restricted Stock Units | 5820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock Options | 12160 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock Options | 6880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Neal James R | Director | M | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock, par value $0.01 | 6980 | $0.00 | 7,042.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock, par value $0.01 | 5820 | $0.00 | 12,862.0000 | 0 | 82.65% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Restricted Stock Units | 6980 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Restricted Stock Units | 5820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock Options | 9580 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock Options | 9580 | $0.00 | 9,580.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock Options | 6880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Csimma Cristina | Director | M | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock, par value $0.01 | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock, par value $0.01 | 5820 | $0.00 | 10,920.0000 | 0 | 114.12% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Restricted Stock Units | 5100 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Restricted Stock Units | 5820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock Options | 12160 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock Options | 6880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Trenschel Robert J. | Director | M | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock, par value $0.01 | 6980 | $0.00 | 6,980.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Restricted Stock Units | 6980 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Restricted Stock Units | 5820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock Options | 9580 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock Options | 9580 | $0.00 | 9,580.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock Options | 6880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Diaz Stephanie | Director | M | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 4558 | $0.00 | 7,482.0000 | 0 | 155.88% | 0.00% |
| Feb. 6, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 2333 | $0.00 | 9,815.0000 | 0 | 31.18% | 0.00% |
| Feb. 6, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 2153 | $0.44 | 7,662.0000 | 0 | 21.94% | 0.00% |
| Feb. 6, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 4558 | $0.00 | 45,586.0000 | 0 | 9.09% | 0.00% |
| Feb. 6, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 2333 | $0.00 | 25,667.0000 | 0 | 8.33% | 0.00% |
| Feb. 6, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3475 | $0.00 | 88,901.0000 | 0 | 4.07% | 0.00% |
| Feb. 6, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3167 | $0.00 | 92,068.0000 | 0 | 3.56% | 0.00% |
| Feb. 6, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3475 | $0.00 | 27,800.0000 | 0 | 11.11% | 0.00% |
| Feb. 6, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3167 | $0.00 | 34,833.0000 | 0 | 8.33% | 0.00% |
| Feb. 6, 2024 | Finley John David | CEO, CFO, Director | P | Common Stock, par value $0.01 | 10000 | $0.47 | 85,426.0000 | 0 | 13.26% | 0.00% |
| Jan. 31, 2024 | Finley John David | CEO, CFO, Director | P | Common Stock, par value $0.01 | 10000 | $0.56 | 75,426.0000 | 0 | 15.28% | 0.00% |
| Jan. 31, 2024 | Williams Donald Allen | Director | P | Common Stock, par value $0.01 | 10000 | $0.61 | 30,000.0000 | 0 | 50.00% | 0.00% |
| Jan. 3, 2024 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 1309 | $0.00 | 65,426.0000 | 0 | 2.04% | 0.00% |
| Jan. 3, 2024 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 1309 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 5559 | $0.00 | 64,117.0000 | 0 | 9.49% | 0.00% |
| Dec. 11, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 5559 | $0.00 | 55,583.0000 | 0 | 9.09% | 0.00% |
| Nov. 21, 2023 | Csimma Cristina | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Wei Binxian | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Wei Binxian | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Williams Donald Allen | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Williams Donald Allen | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 28000 | $0.00 | 28,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | A | Common Stock Options | 33160 | $0.00 | 33,160.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Trenschel Robert J. | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Trenschel Robert J. | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Neal James R | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Neal James R | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Diaz Stephanie | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Diaz Stephanie | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | GRAY MARY ANN | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | GRAY MARY ANN | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Finley John David | CEO, CFO, Director | A | Common Stock, par value $0.01 | 10000 | $0.51 | 58,558.0000 | 0 | 20.59% | 0.00% |
| Nov. 21, 2023 | Finley John David | CEO, CFO, Director | A | Restricted Stock Units | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Finley John David | CEO, CFO, Director | A | Common Stock Options | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | Csimma Cristina | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 6, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3475 | $0.00 | 31,275.0000 | 0 | 10.00% | 0.00% |
| Nov. 6, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 4556 | $0.00 | 4,556.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 1630 | $0.54 | 2,926.0000 | 0 | 35.78% | 0.00% |
| Nov. 6, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 4556 | $0.00 | 50,144.0000 | 0 | 8.33% | 0.00% |
| Nov. 6, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3475 | $0.00 | 48,558.0000 | 0 | 7.71% | 0.00% |
| Oct. 3, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 1309 | $0.00 | 45,480.0000 | 0 | 2.96% | 0.00% |
| Oct. 3, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 1309 | $0.00 | 1,309.0000 | 0 | 50.00% | 0.00% |
| Oct. 4, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 397 | $0.55 | 45,083.0000 | 0 | 0.87% | 0.00% |
| Sept. 27, 2023 | Williams Donald Allen | Director | P | Common Stock, par value $0.01 | 20000 | $0.54 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 27, 2023 | Finley John David | CEO, CFO, Director | P | Common Stock, par value $0.01 | 15000 | $0.54 | 44,171.0000 | 0 | 51.42% | 0.00% |
| Sept. 14, 2023 | Trenschel Robert J. | Director | S | Common Stock, par value $0.01 | 300 | $0.64 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 13, 2023 | Finley John David | CEO, CFO, Director | P | Common Stock, par value $0.01 | 15000 | $0.66 | 29,171.0000 | 0 | 105.85% | 0.00% |
| Sept. 11, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 5558 | $0.00 | 15,963.0000 | 0 | 53.42% | 0.00% |
| Sept. 11, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 5558 | $0.00 | 61,142.0000 | 0 | 8.33% | 0.00% |
| Sept. 12, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 1792 | $0.66 | 14,171.0000 | 0 | 11.23% | 0.00% |
| Aug. 11, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 1040 | $0.70 | 10,405.0000 | 0 | 9.09% | 0.00% |
| Aug. 6, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3475 | $0.00 | 34,750.0000 | 0 | 9.09% | 0.00% |
| Aug. 6, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3475 | $0.00 | 11,834.0000 | 0 | 41.57% | 0.00% |
| July 3, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 1309 | $0.00 | 2,618.0000 | 0 | 33.33% | 0.00% |
| July 6, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 389 | $1.76 | 7,970.0000 | 0 | 4.65% | 0.00% |
| July 3, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 1309 | $0.00 | 8,359.0000 | 0 | 18.57% | 0.00% |
| June 13, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 1050 | $1.54 | 7,050.0000 | 0 | 12.96% | 0.00% |
| June 12, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 3475 | $0.00 | 8,100.0000 | 0 | 75.14% | 0.00% |
| June 12, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 3475 | $0.00 | 38,225.0000 | 0 | 8.33% | 0.00% |
| June 11, 2023 | Trenschel Robert J. | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Neal James R | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | GRAY MARY ANN | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | GRAY MARY ANN | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Diaz Stephanie | Director | A | Common Stock Options | 9580 | $0.00 | 9,580.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Diaz Stephanie | Director | A | Restricted Stock Units | 6980 | $0.00 | 6,980.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Csimma Cristina | Director | A | Common Stock Options | 9580 | $0.00 | 9,580.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Csimma Cristina | Director | A | Restricted Stock Units | 6980 | $0.00 | 6,980.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Wei Binxian | Director | A | Common Stock Options | 9580 | $0.00 | 9,580.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Wei Binxian | Director | A | Restricted Stock Units | 6980 | $0.00 | 6,980.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Trenschel Robert J. | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Finley John David | CEO, CFO, Director | A | Common Stock Options | 148500 | $0.00 | 148,500.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Finley John David | CEO, CFO, Director | A | Restricted Stock Units | 66700 | $0.00 | 66,700.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Williams Donald Allen | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Williams Donald Allen | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | Neal James R | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | McRae Robert Curtis | Chief Operating Officer | F | Common Stock, par value $0.01 | 270 | $2.00 | 625.0000 | 0 | 30.17% | 0.00% |
| April 3, 2023 | McRae Robert Curtis | Chief Operating Officer | M | Restricted Stock Units | 655 | $0.00 | 1,963.0000 | 0 | 25.02% | 0.00% |
| April 3, 2023 | Finley John David | CEO, CFO, Director | M | Common Stock, par value $0.01 | 1309 | $0.00 | 5,060.0000 | 0 | 34.90% | 0.00% |
| April 3, 2023 | Finley John David | CEO, CFO, Director | F | Common Stock, par value $0.01 | 435 | $2.01 | 4,625.0000 | 0 | 8.60% | 0.00% |
| April 3, 2023 | Finley John David | CEO, CFO, Director | M | Restricted Stock Units | 1309 | $0.00 | 3,927.0000 | 0 | 25.00% | 0.00% |
| April 3, 2023 | McRae Robert Curtis | Chief Operating Officer | M | Common Stock, par value $0.01 | 655 | $0.00 | 895.0000 | 0 | 272.92% | 0.00% |
| Feb. 6, 2023 | Finley John David | CEO, CFO, Director | A | Restricted Performance Stock Units | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Finley John David | CEO, CFO, Director | A | Common Stock Purchase Option | 57200 | $0.00 | 57,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Finley John David | CEO, CFO, Director | A | Restricted Stock Units | 41700 | $0.00 | 41,700.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Finley John David | Chief Executive Officer | A | Restricted Stock Units | 5236 | $0.00 | 5,236.0000 | 0 | 9999.99% | 0.00% |